Doxazosin News
Thiazides first-choice antihypertensive even for patients with metabolic syndrome
New findings from ALLHAT fail to support the preference for calcium blockers, alpha blockers, or ACE inhibitors compared with thiazide diuretics in patients with metabolic syndrome, despite their more favorable metabolic profiles...
C&EN talks with Simon Campbell
Simon Campbell is well-known as the chemist who initiated the research project that led to the discovery of Viagra--the first oral treatment for male erectile dysfunction. Over recent years, he also has become increasingly...
Hexion Specialty Chemicals Announces Price Increases for Cardura E10P, Versatic Acids, and Inks Resins
Hexion Specialty Chemicals announced today it will increase the prices of its Cardura and Versatic Acids prices globally effective June 15, 2006, or as contract terms allow. Hexion will increase prices for Versatic Acid grades by...
Doxazosin cytotxic to prostate carcinoma cell lines
Researchers from Turkey report that doxazosin may be a new cytotoxic agent for prostate cancer. Doxazosin killed prostate carcinoma cells in vitro and the effect was synregistic with adriamycin and etoposide.
Why Prostate Drug, Doxazosin, Increases Likelihood Of Heart Failure
Doxazosin, a drug commonly prescribed to help improve urinary flow in men with enlarged prostates, increases the likelihood of heart failure by blocking specific receptors in heart muscle cells, according to a study conducted at...